Advocacy Foundations Bridging Gap Between Research & Drug Development
This article was originally published in The Pink Sheet Daily
Executive Summary
Observers say that research foundations are moving away from funding pure science to behaving more like venture capitalists. Groups like the Cystic Fibrosis Foundation are awarding grants for Phase I and II clinical trials as well as operating nonprofit drug development firms.
You may also be interested in...
Gilead Prices Cystic Fibrosis Drug Cayston At Slight Premium To Competitor
Gilead Sciences will price its cystic fibrosis drug Cayston at an 8 percent premium to its competitor, Novartis' TOBI (tobramycin)
Profound Beauty Grows Virtual Presence To Avoid Going Mass
"Personalized" hair-care firm Profound Beauty is growing its presence online to attract new customers while preserving its status as a prestige brand